StrideBio Expands Leadership Team with Appointment of William Monteith as Chief Operating Officer

RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2020 -- (Healthcare Sales & Marketing Network) -- StrideBio, Inc, a leading developer of novel engineered adeno-associated virus (AAV) based gene therapies, today announced the appointment of William (Bill) Monteith ... Biopharmaceuticals, Personnel StrideBio , gene therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news